Avagliano Mark

Track

Insider profile

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return 11% 8.2% 15.1%
Success rate 74% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Avagliano Mark's trades of G1 Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
421.03
Quantity 48,721 -35.8%
Value US$4,099,930
Transaction date
Sale
Price
67.95
Quantity 90,277 -38.3%
Value US$241,685
Transaction date
Sale
Price
22.99
Quantity 23,502 +36.4%
Value US$2,458,245
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-07-08 2024-07-05
S Sale
48,721 -35.8%
421.03
US$4,099,930 		48,721 -35.8% 421.03 US$4,099,930
2024-05-15 2024-05-13
S Sale
90,277 -38.3%
67.95
US$241,685 		90,277 -38.3% 67.95 US$241,685
2024-01-08 2024-01-04
S Sale
23,502 +36.4%
22.99
US$2,458,245 		23,502 +36.4% 22.99 US$2,458,245
2024-01-08 2024-01-03
S Sale
2,602 -2.1%
3.12
US$8,115 		2,602 -2.1% 3.12 US$8,115
2024-01-08 2024-01-03
S Sale
758 -0.6%
3.12
US$2,364 		758 -0.6% 3.12 US$2,364
2022-01-05 2022-01-05
S Sale
1,445 -6.3%
10.61
US$15,334 		1,445 -6.3% 10.61 US$15,334